HealthEquity Reports Second Quarter Ended July 31, 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. JNJ
6. PLTR
7. DMART:IN
8. HUM
9. CSCO
10. KTOS

Go back to HealthEquity Reports Second Quarter Ended July 31, 2017 Financial Results

Oppenheimer Remains Bullish on HealthEquity (HQY) Following Solid 2Q

September 6, 2017 9:44 AM EDT

Oppenheimer reiterated an Outperform rating and $61.00 price target on HealthEquity, Inc (NASDAQ: HQY) following the company's 2Q earnings report. Revenues of $56.9M beat estimates of $55.8M and adjusted EPS of $0.27 beat estimates of $0.18, mainly on tax benefits.

HQY raised its FY18... More

HealthEquity (HQY) Tops Q2 EPS by 12c, Sales Rise 29%; Raises Outlook

September 5, 2017 4:09 PM EDT

HealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.27, $0.12 better than the analyst estimate of $0.15. Revenue for the quarter came in at $56.9 million versus the consensus estimate of $55.66 million.

Revenue of $56.9 million, an increase of 29% compared to Q2 FY17.Net income of $16.9 million, an increase of 106% compared to Q2 FY17.Net income per diluted share of $0.27 compared to $0.14 in Q2 FY17.Adjusted EBITDA of $23.9 million, an increase of 30% compared to Q2... More